COVID-19 infection as a parameter in the CHA2DS2 vascular risk assessment tool.
作者信息
Jolobe Oscar M P
机构信息
Manchester, UK.
出版信息
Clin Med (Lond). 2023 Nov;23(6):646-647. doi: 10.7861/clinmed.Let.23.6.2.
Abstract
摘要
相似文献
1
COVID-19 infection as a parameter in the CHA2DS2 vascular risk assessment tool.新型冠状病毒肺炎感染作为CHA2DS2血管风险评估工具中的一个参数。
Clin Med (Lond). 2023 Nov;23(6):646-647. doi: 10.7861/clinmed.Let.23.6.2.
2
CHADS-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation.CHADS-VASc评分与非房颤急性缺血性卒中患者的预后相关。
Tex Heart Inst J. 2025 Feb 4;52(1):e248450. doi: 10.14503/THIJ-24-8450. eCollection 2025 Jan-Jun.
3
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.GARFIELD-AF 评分用于预测房颤患者 2 年内的死亡、卒中和出血风险。
Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):214-227. doi: 10.1093/ehjqcco/qcab028.
4
Ischemic stroke risk in East Asian patients with CHADS-VASc score of 1: systematic review and meta-analysis.CHADS-VASc评分为1的东亚患者的缺血性卒中风险：系统评价与荟萃分析
Expert Rev Cardiovasc Ther. 2017 Feb;15(2):145-150. doi: 10.1080/14779072.2017.1281742. Epub 2017 Jan 20.
5
Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis.CHA2DS2-VASc 评分在心房颤动中的预测性能：系统评价和荟萃分析。
J Thromb Haemost. 2017 Jun;15(6):1065-1077. doi: 10.1111/jth.13690. Epub 2017 May 9.
6
7
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
8
CHADS-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis.CHA2DS2-VASc 风险因素对急性冠脉综合征后卒中的预测作用：系统评价和荟萃分析。
Eur Heart J Acute Cardiovasc Care. 2018 Apr;7(3):264-274. doi: 10.1177/2048872616673536. Epub 2016 Oct 5.
9
The Predictive Value of the CHADS-VASc Score in the Development of Contrast-Induced Nephropathy after Endovascular Intervention in Peripheral Artery Disease.CHADS-VASc评分对周围动脉疾病血管内介入术后对比剂肾病发生的预测价值
Ann Vasc Surg. 2025 Jul;116:17-26. doi: 10.1016/j.avsg.2025.03.009. Epub 2025 Mar 26.
10
Association of HARMS-AF score with atrial tachyarrhythmia recurrence after radiofrequency catheter ablation: a retrospective observational study.HARMS-AF评分与射频导管消融术后房性快速性心律失常复发的相关性：一项回顾性观察研究。
BMC Cardiovasc Disord. 2025 Aug 28;25(1):636. doi: 10.1186/s12872-025-05110-y.
本文引用的文献
1
Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients prescribed anticoagulants at discharge.与下呼吸道感染相比，住院 COVID-19 患者新发心房颤动的发生率更高，然而，出院时开具抗凝药物的患者较少。
Clin Med (Lond). 2023 Sep;23(5):478-484. doi: 10.7861/clinmed.2023-0188.
2
COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patients.COVID-19 增加了住院患者发生心房颤动的风险。
Sci Rep. 2022 Jul 14;12(1):12014. doi: 10.1038/s41598-022-16113-6.
3
High-dimensional characterization of post-acute sequelae of COVID-19.高维刻画 COVID-19 后遗留症状。
Nature. 2021 Jun;594(7862):259-264. doi: 10.1038/s41586-021-03553-9. Epub 2021 Apr 22.
4
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.新型冠状病毒肺炎中的高凝状态：发生率、病理生理学和管理。
Thromb Res. 2020 Oct;194:101-115. doi: 10.1016/j.thromres.2020.06.029. Epub 2020 Jun 20.
Zotero 插件